Management issues with elderly-onset rheumatoid arthritis: an update

Area of Science:

• Rheumatology
• Geriatric Medicine
• Immunology

Background:

• Elderly-onset rheumatoid arthritis (EORA) affects individuals over 60, differing from younger-onset RA with a lower female-to-male ratio and acute onset.
• EORA may present with classical RA or a polymyalgia rheumatica-like syndrome, distinguished by shoulder involvement and absence of rheumatoid factor.
• Differential diagnosis includes polymyalgia rheumatica, spondyloarthritis, and other inflammatory arthropathies.

Purpose of the Study:

• To outline the distinct characteristics of EORA.
• To discuss diagnostic considerations for EORA.
• To review treatment strategies and challenges in elderly patients with RA.

Main Methods:

• Literature review of EORA characteristics.
• Analysis of diagnostic criteria and differential diagnoses.
• Evaluation of therapeutic options and risk management in EORA.

Main Results:

• EORA exhibits unique clinical and demographic features compared to RA in younger patients.
• Anti-cyclic citrullinated peptide antibodies aid in differentiating EORA subsets from polymyalgia rheumatica.
• Age-related comorbidities necessitate cautious treatment selection.

Conclusions:

• Accurate diagnosis of EORA is essential, considering its varied presentations and differential diagnoses.
• Treatment of EORA requires careful risk-benefit assessment due to increased patient vulnerability.
• Newer agents like leflunomide and TNF-alpha inhibitors offer expanded therapeutic options for elderly RA patients.